SCHEMBL597392

SCHEMBL597392

[CH2]OCC(=O)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21901723 0.79
SCHEMBL2682415 0.78 GAA (0.60)
SCHEMBL4677300 0.77 GAA (0.52)
Formaldehyde SCHEMBL9514376 0.77 GAA (0.52)
SCHEMBL77241 0.76
SCHEMBL123093 0.76
SCHEMBL27411503 0.76 ALDH1A1 (0.63)
SCHEMBL9995139 0.76
SCHEMBL9838596 0.75 ALDH1A1 (0.81)
SCHEMBL5364605 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149439-A1 PYRIDYLMETHYSULFONE DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-06-11 US claimed
US-20090105292-A9 Glucocorticoid Receptor Modulator Compounds and Methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-04-23 US claimed
EP-1867636-A1 PYRIDYLMETHYLSULFONE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2007-12-19 EP claimed
US-20070281959-A1 Glucocorticoid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2007-12-06 US claimed
EP-1718653-A1 GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY Ligand Pharmaceuticals Inc. (US) 2006-11-08 EP claimed
WO-2005082909-A1 GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY LIGAND PHARMACEUTICALS INCORPORATED (US) 2005-09-09 WO claimed
EP-0832082-B1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ASTRAZENECA AB (SE) 2001-11-21 EP claimed
EP-0832082-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1998-04-01 EP claimed
WO-1996040681-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1996-12-19 WO claimed
US-4144240-A USED FOR MODIFYING CEPHALOSPORINS PFIZER INC. (US) 1979-03-13 US claimed
US-8114886-B2 Pyridylmethylsulfone derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-02-14 US disclosed
US-7556911-B2 Titanocene based compound, photosensitive composition, photosensitive transfer sheet and pattern forming method FUJIFILM CORPORATION (JP) 2009-07-07 US disclosed
US-20090149439-A1 PYRIDYLMETHYSULFONE DERIVATIVE DAIICHI SANKYO COMPANY LIMITED (JP) 2009-06-11 US disclosed
US-20090105292-A9 Glucocorticoid Receptor Modulator Compounds and Methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-04-23 US disclosed
EP-1867636-A1 PYRIDYLMETHYLSULFONE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2007-12-19 EP disclosed
EP-0156771-A2 Cephalosporins BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1985-10-02 EP disclosed
US-4477448-A CONTAIN PYRAZOLE SUBSTITUENTS SANDOZ LTD. (CH) 1984-10-16 US disclosed
EP-0037380-B1 NEW PROCESS FOR THE PRODUCTION OF CEPHALOSPORIN ANTIBIOTICS, AND NOVEL INTERMEDIATES USED IN SUCH PROCESS AND THEIR PRODUCTION BIOCHEMIE Gesellschaft m.b.H. (AT) 1984-09-12 EP disclosed
WO-1984000547-A1 FLUORALKYLATEDCARBAPENEM DERIVATIVES SANDOZ AG (AT) 1984-02-16 WO disclosed
EP-0037380-A2 New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production BIOCHEMIE Gesellschaft m.b.H. (AT) 1981-10-07 EP disclosed